MFN2 and metabolic dysfunction-associated steatohepatitis: According to a previous study, hepatic Mfn2 deficiency reduced PS transfer and phospholipid synthesis, leading to endoplasmic reticulum stress and the development of a NASH-like phenotype and liver cancer; this finding indicated that hepatic PS might be a protective factor against the development of advanced liver diseases [25].